Warning: Trying to access array offset on false in /var/www/vhosts/hemostasistoday.com/public_html/pub/themes/hemostasis/single.php on line 25
Warning: Trying to access array offset on false in /var/www/vhosts/hemostasistoday.com/public_html/pub/themes/hemostasis/single.php on line 26
15% Recanalization Rate During Transfer in Basilar Artery Occlusion: A Missed Opportunity?
International Journal of Stroke (IJS) shared a new study on X:
”Study finds BAO recanalization during interhospital transfer for thrombectomy was associated with favorable 3-month outcome. Primary modifiable factor, yet its use remains low.”
Read the full article here.
Lately published article ”Recanalization of Basilar Artery Occlusion during Interhospital Transfer for Thrombectomy” in the International Journal of Stroke by Grace Adwane et al. sheds light on the possible opportunities with intravenous thrombolysis.
Patients with acute ischemic stroke due to basilar artery occlusion (BAO) often require transfer from non-endovascular capable centers to comprehensive stroke centers for thrombectomy.
New data show that 15% of these patients achieve recanalization during transfer, which is linked to better 3-month outcomes.
However, the use of intravenous thrombolysis (IVT) — the main modifiable factor promoting recanalization — remains underutilized at referring centers.
Expanding IVT access and exploring additional recanalization therapies at the primary stroke center level could help bridge this treatment gap and improve patient outcomes.
All the latest advancements in the field of stroke management featured in Hemostasis Today.
-
Oct 25, 2025, 10:13Meet the 2025 WSO Award Winners for Their Extensive Contributions to Stroke Science
-
Oct 25, 2025, 09:53Aakanksha A Shares The 1st Post in ASH 12-Part Microlearning Series
-
Oct 25, 2025, 09:22Alessandro Bufi Presented SAIDE Project at World Stroke Congress 2025
-
Oct 25, 2025, 09:06A Short Story About a Platelet Named Pippa from Krista Goerger
-
Oct 25, 2025, 08:31Maxime Dely: What if We Could Leukoreduce Without a Filter?
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 24, 2025, 11:41Yaping Zhang on Platelet Adhesion Receptors
-
Oct 24, 2025, 11:37Omid Jafari and Colleagues Present the VTE-BERT Natural Language Processing Model
-
Oct 24, 2025, 11:34Insights on IV Thrombolysis and Mechanical Thrombectomy from Benjamin Maier and Colleagues
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!
-
Oct 25, 2025, 08:14Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize